Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Eisai develops novel retinoids as highly potent and selective RXR agonists

Dec. 15, 1997

Genzyme Transgenics' idiotypic vaccines show promise in clinical trials

Dec. 12, 1997

MKT-077: a novel antitumor rhodacyanine dye in clinical testing

Dec. 11, 1997

Profile of novel topoisomerase II inhibitor, ER-37328, from Eisai

Dec. 11, 1997

Protein farnesyltransferase inhibitors focus of research at Merck & Co.

Dec. 11, 1997

ImClone Systems' C225 enters phase II for metastatic renal cell carcinoma

Dec. 11, 1997

SDZ-PSC-833 increases oral bioavailability of paclitaxel

Dec. 10, 1997

Oncologic Drugs Advisory Committee meets next week

Dec. 10, 1997

Preclinical toxicity profile of ISIS-2503

Dec. 9, 1997

SunPharm's anticancer drug completes phase I

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.